Both Johnson & Johnson and AstraZeneca are nearing the end of their trials and are anxious to get their vaccines to market as soon as possible.
Both Johnson & Johnson and AstraZeneca are nearing the end of their trials and are anxious to get their vaccines to market as soon as possible.